Trabectedin is an alkylating agent registered in Europe for the treatment of advanced metastatic soft-tissue sarcomas, whose activity has been documented mainly in liposarcomas or leiomyosarcomas. Here, we report the response achieved in a patient with lung metastases from synovial sarcoma. A man with a large synovial sarcoma of the axilla...
-
2014 (v1)PublicationUploaded on: April 14, 2023
-
2020 (v1)Publication
Despite the current immunotherapy era, VEGFR inhibitors maintain effectiveness in metastatic renal cell cancer. Real-world data concerning pazopanib are limited. The aim of this study is to add information about efficacy and safety of pazopanib as first-line treatment in metastatic renal cell cancer patients not enrolled into clinical trials.
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2022 (v1)Publication
Background: The addition of neutrophil-to-lymphocyte ratio (NLR) and bone metastases to the International Metastatic RCC Database Consortium (IMDC) score (by the Meet-URO score) has been shown to better stratify pretreated metastatic renal cell carcinoma (mRCC) patients receiving nivolumab. This study aimed to validate the Meet-URO score in...
Uploaded on: April 14, 2023 -
2016 (v1)Publication
This retrospective multicenter survey analyzed modalities of dose calculation, dose reductions, acute toxicities, and relapse rate of adjuvant AUC 7 carboplatin in 115 stage I seminoma patients. The study confirms the feasibility and safety of AUC 7 carboplatin in every day clinical practice with a relapse rate of 5.2%. Dose reduction should be...
Uploaded on: October 11, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2023 (v1)Publication
No description
Uploaded on: February 11, 2024